Review ArticleClinical StudiesR
Update on PEG-Interferon α-2b as Adjuvant Therapy in Melanoma
ROSSELLA DI TROLIO, ESTER SIMEONE, GIUSEPPE DI LORENZO, ANTONIO MARIA GRIMALDI, ANNA ROMANO, FABRIZIO AYALA, CORRADO CARACÒ, NICOLA MOZZILLO and PAOLO A. ASCIERTO
Anticancer Research September 2012, 32 (9) 3901-3909;
ROSSELLA DI TROLIO
1Unit of Medical Oncology and Innovative Therapy, G. Pascale Institute of National Tumor Foundation, Naples, Italy
ESTER SIMEONE
1Unit of Medical Oncology and Innovative Therapy, G. Pascale Institute of National Tumor Foundation, Naples, Italy
GIUSEPPE DI LORENZO
2Medical Oncology, Department of Endocrinology and Oncology, Federico II University, Naples, Italy
ANTONIO MARIA GRIMALDI
1Unit of Medical Oncology and Innovative Therapy, G. Pascale Institute of National Tumor Foundation, Naples, Italy
ANNA ROMANO
1Unit of Medical Oncology and Innovative Therapy, G. Pascale Institute of National Tumor Foundation, Naples, Italy
FABRIZIO AYALA
1Unit of Medical Oncology and Innovative Therapy, G. Pascale Institute of National Tumor Foundation, Naples, Italy
CORRADO CARACÒ
3Unit of Surgery, Department of Melanoma, Sarcoma, and Head and Neck Cancers, G. Pascale Institute of National Tumor Foundation, Naples, Italy
NICOLA MOZZILLO
3Unit of Surgery, Department of Melanoma, Sarcoma, and Head and Neck Cancers, G. Pascale Institute of National Tumor Foundation, Naples, Italy
PAOLO A. ASCIERTO
1Unit of Medical Oncology and Innovative Therapy, G. Pascale Institute of National Tumor Foundation, Naples, Italy
In this issue
Anticancer Research
Vol. 32, Issue 9
September 2012
Update on PEG-Interferon α-2b as Adjuvant Therapy in Melanoma
ROSSELLA DI TROLIO, ESTER SIMEONE, GIUSEPPE DI LORENZO, ANTONIO MARIA GRIMALDI, ANNA ROMANO, FABRIZIO AYALA, CORRADO CARACÒ, NICOLA MOZZILLO, PAOLO A. ASCIERTO
Anticancer Research Sep 2012, 32 (9) 3901-3909;
Jump to section
Related Articles
- No related articles found.
Cited By...
- The FOXC2 Transcription Factor Promotes Melanoma Outgrowth and Regulates Expression of Genes Associated With Drug Resistance and Interferon Responsiveness
- Natural Killer Cells Are Essential for the Ability of BRAF Inhibitors to Control BRAFV600E-Mutant Metastatic Melanoma
- IFN-{alpha} Inhibits Telomerase in Human CD8+ T Cells by Both hTERT Downregulation and Induction of p38 MAPK Signaling